Gnädinger M P, Lang R E, Hasler L, Uehlinger D E, Shaw S, Weidmann P
Miner Electrolyte Metab. 1986;12(5-6):371-4.
Atrial natriuretic peptides (ANPs) circulate in the blood stream and may modulate the regulation of blood pressure, sodium-fluid volume state and renal function. In man, alpha-human ANP (alpha hANP) is probably the major circulating form of ANP. To evaluate its plasma kinetics, we studied in 7 healthy men plasma alpha hANP concentrations under basal conditions and at short intervals during and up to 40 min after discontinuation of a 45-min constant alpha hANP infusion at a rate of 0.1 microgram/min/kg. From basal levels averaging 75 +/- 18 pg/ml (mean +/- SEM), plasma alpha hANP concentrations increased to 1,185 +/- 321 and 1,117 +/- 175 pg/ml at 30 and 40 min during the alpha hANP infusion, respectively. After discontinuing the latter, plasma alpha hANP decreased rapidly, following first-order kinetics, with a plasma half-life of 3.2 +/- 0.4 min. This finding is in line with the brief effects of intravenously applied alpha hANP and suggests that this system may be designed for rapid minute-to-minute adjustments.
心房利钠肽(ANPs)在血流中循环,可能调节血压、钠液量状态和肾功能。在人类中,α-人ANP(αhANP)可能是ANP的主要循环形式。为了评估其血浆动力学,我们对7名健康男性进行了研究,在基础条件下以及以0.1微克/分钟/千克的速率持续输注αhANP 45分钟期间及停止输注后40分钟内的短时间间隔内,测定血浆αhANP浓度。基础水平平均为75±18皮克/毫升(平均值±标准误),在αhANP输注期间,30分钟和40分钟时血浆αhANP浓度分别升至1185±321和1117±175皮克/毫升。停止输注后,血浆αhANP迅速下降,遵循一级动力学,血浆半衰期为3.2±0.4分钟。这一发现与静脉应用αhANP的短暂作用一致,表明该系统可能是为了进行快速的每分钟调节而设计的。